June 30, 2010
A Settlement Agreement in the Canadian Zyprexa class actions has now been approved by the Canadian Courts. The class actions were brought on behalf of Canadian patients who used the antipsychotic Zyprexa (olanzapine) prior to June 6, 2007. If you, or a family member in your care, ingested Zyprexa prior to June 6, 2007 and developed diabetes, hyperglycemia, ketoacidosis or pancreatitis potentially associated with its use you may be eligible to receive compensation. Please click here to view the notice published in the Vancouver Sun on June 30, 2010. Please read this notice carefully as it may affect your legal rights and you may be eligible for compensation.
To view the full legal notice, click here.
To view the Press Release, click here.
To view the Claim Form Package, click here. The Claim Form Package can be downloaded and printed or a copy can be obtained by contacting the Claims Administrator at:
Zyprexa Claims Administrator
Suite 3 - 505 133 Weber Street
Waterloo, Ontario N2J 3G9
Telephone: 1-877-739-8933
Email: zyprexa@crawco.ca
Website: www.zyprexasettlement.ca
ALL REQUIRED CLAIM FORMS AND SUPPORTING DOCUMENTATION MUST BE SUBMITTED BY OCTOBER 28, 2010 TO THE CLAIMS ADMINISTRATOR AT THE ADDRESS ABOVE.
To view the approved Settlement Agreement, click here.
British Columbia residents who wish to preserve their right to sue the Defendants on an individual basis and who do not want to be covered by the Settlement Agreement must opt out by September 28, 2010. Opt Out Forms can be obtained by contacting the Claims Administrator. You do not need to opt out if you simply do not wish to make a claim.
For further information, email or phone 604-988-6321.
This Web site is offered for information only and is not legal advice. Use of the site and sending or receiving information through it does not establish an attorney-client relationship. No one should act, or refrain from acting, based solely upon this information without seeking appropriate legal or other professional advice. In particular, you should obtain advice about limitation periods as it may affect your right to bring a legal action on your own behalf. Links to and from this Web site do not state or imply a relationship between Poyner Baxter LLP and the linked entity.
